Fluvastatin Sodium Salt Synthesis via Selective Hydrolysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing processes for preparing Fluvastatin Sodium salt face challenges in minimizing the content of the unwanted anti isomer, which is a major impurity and degrades easily, requiring multiple crystallizations of its t-butyl ester precursor, resulting in significant yield loss.
Innovation Solution
The saponification step is conducted in a suitable aqueous alcoholic solution using less than 1.00 molar amount of sodium hydroxide, allowing selective hydrolysis of the syn Fluvastatin alkyl ester while leaving most of the anti isomer unhydrolyzed, followed by extraction with a solvent like t-butyl methyl ether to achieve a low anti isomer content in the Fluvastatin Sodium salt.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If multiple crystallizations of t-butyl ester precursor are performed to minimize anti isomer content, then purity of Fluvastatin Sodium salt is improved, but yield loss increases significantly
Solution Approach 1:
The invention changes the chemical parameter by using sub-stoichiometric amounts of base (0.4-0.95 equivalents instead of excess base) to achieve selective hydrolysis. This parameter change allows the syn isomer to be hydrolyzed to the salt while the anti isomer remains as unreactive ester, reversing the traditional approach where excess base was used to ensure complete hydrolysis of all esters
Solution Approach 2:
The invention extracts the unwanted anti isomer from the reaction mixture by maintaining it in its unhydrolyzed ester form while converting the desired syn isomer to its water-soluble salt form. The anti isomer ester can then be separated from the aqueous layer containing the Fluvastatin Sodium salt, effectively removing the impurity without requiring multiple crystallization cycles
2Quantity of substance
If traditional saponification with excess base is used, then complete hydrolysis of ester is achieved, but selective removal of anti isomer becomes difficult
Solution Approach 1:
The invention applies partial action by using less than stoichiometric amounts of base (0.4-0.95 equivalents) instead of excess base. This deliberate use of insufficient base creates selective hydrolysis where only the more reactive syn isomer is converted to salt while the anti isomer remains as ester, enabling easy separation
Solution Approach 2:
The invention creates local quality differences by treating the two diastereomers differently through selective hydrolysis. The syn isomer undergoes complete hydrolysis to water-soluble salt while the anti isomer remains as insoluble ester, creating a system where the two isomers have fundamentally different solubility properties that facilitate separation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces the anti isomer content to less than half of the initial ester material, improving the purity of Fluvastatin Sodium salt without substantial yield loss, unlike traditional methods, and allows for high-yield, high-purity production without the need for multiple crystallizations.
Implementation Method 1
saponification step in a suitable aqueous alcoholic solution using less than 1.00 molar amount of sodium hydroxide in respect to the ester allows hydrolyzing selectively the syn Fluvastatin alkyl ester
Implementation Method 2
The residual small amount of Fluvastatin alkyl ester (enriched with the unwanted anti isomer) may be removed by extraction with a suitable solvent, such as t-butyl methyl ether
Data Source
AI summary
The present invention is directed to a process for preparing Fluvastatin Sodium salt by basic hydrolysis of its alkyl ester. The reaction is performed in conditions suitable to allow a selective hydrolysis of the desired syn isomer, while the unwanted anti isomer is removed by extraction, thus reducing its content in the final product; this diastereomer is the main impurity of Fluvastatin sodium salt and its ester precursor.